-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) Misses Q1 EPS by 124c
-
-
-
-
-
-
-
Increasing unusual option volume: KPTI TWO EWT CDNS DBA ORBS ACHV BOX
-
-
-
-
-
-
-
Rodman & Renshaw Starts Karyopharm Therapeutics (KPTI) at Buy, PT $28
-
-
-
-
-
-
-
Piper Sandler Highlights Karyopharm Therapeutics (KPTI) As a 2026 Top Pick
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) Misses Q2 EPS by 432c
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) Announces 1:15 Reverse Share Split
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) PT Raised to $5 at Piper Sandler
-
439,892 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

